Retraction notice to “miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer”[Biomed. Pharmacother. 86 (2017) 248–253]

IF 7.5 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Biomedicine & Pharmacotherapy Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI:10.1016/j.biopha.2024.117776

Tianjun Chen, Hui Ren, Asmitanand Thakur, Tian Yang, Yang Li, Shuo Zhang, Ting Wang, Mingwei Chen

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

关于“miR-382通过靶向SETD8抑制非小细胞肺癌的肿瘤进展”的撤回通知[Biomed。药学杂志，86(2017)248-253。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Biomedicine & Pharmacotherapy 医学-药学

CiteScore

11.90

自引率

2.70%

发文量

1621

审稿时长

48 days

期刊介绍： Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.

期刊最新文献

Ovarian radiation injury and protection: Mechanisms, delivery-enabled interventions, and future directions Inhibition of miR-320 alleviates hepatic steatosis and dyslipidemia via suppressing the transcription of APOE in MASLD Variant-dependent pharmacological rescue of phenylalanine hydroxylase supports a precision therapeutic strategy for phenylketonuria Therapeutic potential of hybridized nanoparticles embedded with hydrophobic and hydrophilic metallic elements: An optical thermometry approach Pyridine- and quinoline-based piperazine nitriles: Potent and selective 5-HT3 receptor agonists and efficacious desensitizers